Amount Raised
$85 Million
Investors
Slr Capital PartnersMutual Capital PartnersRc CapitalRevelation Partners
Description
SPR Therapeutics raised $85m in financing, including $25m in Series D-1 insider equity and a $60m debt facility. The equity financing was led by Revelation Partners, SPR’s lead investor of the Series D equity financing, and incumbent investors, RC Capital and Mutual Capital Partners. The debt facility was provided by SLR Capital Partners. The company intends to use the funds to capitalize on commercial momentum, customer demand, and market opportunity to expand its sales representation in additional U.S
Funding Insights
Based on industry dataVC-backed spending patterns
VC-backed companies spend 89% more on sales and 100% more on marketing than bootstrapped peers
Tech investment trends
83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech